Zymeworks Inc. Common Stock (ZYME)
Healthcare
Biotechnology
21.90 $
-3.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Zymeworks Inc. Common Stock (ZYME) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -46 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.4 | -43 | 14 | -38 | -25 | -5.9 | -42 | -3.4 | 12 | -31 | -10.0 | -46 | -75 | |
| 4.5 | 6.5 | 3.3 | 2.3 | 2.5 | 2.7 | 3.7 | 3.3 | 3.2 | 2.6 | 1.7 | 2.8 | 10 | |
| 0.4 | 2.0 | 3.4 | 3.6 | 4.6 | 4.7 | 5.0 | 6.4 | 5.9 | 6.9 | -3.4 | 6.9 | 16 | |
| 0.9 | 1.4 | – | – | – | – | – | – | – | – | – | – | – | |
| 39 | -22 | 21 | -11 | -10 | 17 | -27 | 10.0 | -0.2 | -21 | 19 | -11 | -13 | |
| 0.8 | 1.1 | 1.8 | 0.7 | 1.1 | 1.0 | 0.3 | 0.3 | 0.9 | 0.4 | 0.6 | 0.2 | 2.1 | |
| -61 | -7.0 | -1.3 | -7.3 | -20 | 72 | -6.2 | 12 | 8.7 | 0.4 | 5.1 | 70 | 84 | |
| – | – | 820 | 0.4 | – | -21 | -9.4 | 0.0 | – | 1,425 | -25 | -76 | – | |
| 0.0 | 0.0 | – | – | – | 0.0 | 0.0 | – | – | – | – | – | – | |
| 28 | 1.9 | 51 | 2.1 | 1.1 | -15 | -8.6 | 1.3 | 1.3 | -2.5 | -19 | 179 | 159 | |
| -39 | -48 | 63 | -43 | -44 | 51 | -56 | 10 | 22 | -33 | -24 | 203 | 168 | |
| -7.2 | -44 | 12 | -38 | -26 | -6.9 | -42 | -3.7 | 11 | -32 | -11 | -46 | -77 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.